SPONSOR
Vejle Hospital
Total Trials
3
Recruiting
3
Phases
Phase 3
Conditions studied: Cancer of RectumBreast CancerProstate CancerLung CancerGynaecologic CancerColorectal CancerPancreatic Cancer MetastaticCOPDBreathlessnessCannabis
Vejle Hospital is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Cancer of Rectum, Breast Cancer, Prostate Cancer, Lung Cancer.
The trial portfolio spans Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Vejle Hospital
How many clinical trials has Vejle Hospital sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by Vejle Hospital, of which 3 are actively recruiting participants. These trials cover conditions including Cancer of Rectum, Breast Cancer, Prostate Cancer. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Vejle Hospital research focus on?
Vejle Hospital clinical trials span Cancer of Rectum, Breast Cancer, Prostate Cancer, Lung Cancer, Gynaecologic Cancer, and additional conditions. The research pipeline includes Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Vejle Hospital clinical trial?
To participate in a Vejle Hospital trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Vejle Hospital trials with current recruitment status updated daily.
Clinical Trials by Vejle Hospital
NCT04095299 Phase 3
Recruiting
Standard Dose Versus High Dose of Radiotherapy in Rectal Preservation With Chemo-radiotherapy in Rectal Cancer Patients
Cancer of Rectum
NCT07201194
Recruiting
Holistic Acupuncture for Patients With Chemotherapy Induced Nausea
Breast Cancer
NCT06473701 Phase 3
Recruiting
Reducing Breathlessness With Dronabinol in COPD Patients
COPD
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology